DoseVue N.V. was founded in March 2013 by Emiliano D'Agostino and the Belgian Nuclear Research Center (SCK•CEN). DoseVue is the first spin-off company at SCK•CEN, an internationally renowned player in the field of radiation protection and dosimetry research, and one of the most important suppliers of medical radio isotopes worldwide. In the past years DoseVue is developing an entire portfolio of non-invasive and minimally invasive technologies for in-vivo dosimetry and a new product line dedicated to preclinical and clinical quality insurance. Products are already present on the market.
Design and optimisation of a dosimetry platform based on optical fibers for real-time multi-point dose monitoring in patients